What conditions have the most trials recruiting in Gleizé, France?

In Gleizé, France, the conditions with the most recruiting trials are ALK+ Non-Small-Cell Lung Carcinoma (1), Breast Cancer (1), COPD (1).

Clinical trials recruiting in Gleizé, France

Recruiting trials

Conditions

Phase 3 1Not applicable 2

Condition	Trials
ALK+ Non-Small-Cell Lung Carcinoma	1
Breast Cancer	1
COPD	1
Chronic Obstructive Pulmonary Disease	1
Lung cancer	1

Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
NCT06487078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
NCT07566195 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
REBECCA Real-world Early BrEast CanCer mAnagement
NCT06856343 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

3 recruiting trials have at least one study site in Gleizé, France.

No. For the full record, search ClinicalTrials.gov.